ID

17301

Beschrijving

Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00600366

Link

https://clinicaltrials.gov/show/NCT00600366

Trefwoorden

Versies (1)
  1. 05-09-16 05-09-16 -
Geüploaded op

5 september 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Diabetes NCT00600366

Engels

Eligibility Diabetes NCT00600366

1 Formulieren  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00600366
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes
Beschrijving

Diabetes Mellitus, Non-Insulin-Dependent

Datatype

boolean

Alias
UMLS CUI [1]
C0011860
insulin naive diabetes
Beschrijving

Insulin Therapy naive Diabetes

Datatype

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0919936
UMLS CUI [1,3]
C0011847
current treatment with oha, secondary failure
Beschrijving

Oral hypoglycemic Therapeutic procedure failed secondary

Datatype

boolean

Alias
UMLS CUI [1,1]
C0359086
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0231175
UMLS CUI [1,4]
C0205436
body mass index (bmi) below 40 kg/m2
Beschrijving

Body mass index

Datatype

boolean

Alias
UMLS CUI [1]
C1305855
hba1c over 8.5%
Beschrijving

Glycosylated hemoglobin A

Datatype

boolean

Alias
UMLS CUI [1]
C0019018
willing and able to start with insulin therapy and to perform self-blood glucose monitoring
Beschrijving

Insulin regime Willing | Blood Glucose Self-Monitoring Willing

Datatype

boolean

Alias
UMLS CUI [1,1]
C0557978
UMLS CUI [1,2]
C0600109
UMLS CUI [2,1]
C0005803
UMLS CUI [2,2]
C0600109
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of drug or alcohol abuse
Beschrijving

Substance Use Disorders

Datatype

boolean

Alias
UMLS CUI [1]
C0038586
receipt of the investigational drug within the last month prior to this trial
Beschrijving

Investigational New Drugs

Datatype

boolean

Alias
UMLS CUI [1]
C0013230
known or suspected allergy to trial products or related products
Beschrijving

Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related Investigational New Drugs

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0439849
UMLS CUI [2,4]
C0013230
severe uncontrolled hypertension
Beschrijving

Uncontrolled hypertension Severe

Datatype

boolean

Alias
UMLS CUI [1,1]
C1868885
UMLS CUI [1,2]
C0205082
any disease or condition, which the investigator feels, would interfere with the trial
Beschrijving

Disease Interferes with Clinical Trial | Condition Interferes with Clinical Trial

Datatype

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0008976
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0008976
Terug naar het begin van de pagina

Similar models

Eligibility Diabetes NCT00600366

1 Formulieren
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00600366
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Insulin Therapy naive Diabetes
Item
insulin naive diabetes
boolean
C0021641 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
C0011847 (UMLS CUI [1,3])
Oral hypoglycemic Therapeutic procedure failed secondary
Item
current treatment with oha, secondary failure
boolean
C0359086 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0205436 (UMLS CUI [1,4])
Body mass index
Item
body mass index (bmi) below 40 kg/m2
boolean
C1305855 (UMLS CUI [1])
Glycosylated hemoglobin A
Item
hba1c over 8.5%
boolean
C0019018 (UMLS CUI [1])
Insulin regime Willing | Blood Glucose Self-Monitoring Willing
Item
willing and able to start with insulin therapy and to perform self-blood glucose monitoring
boolean
C0557978 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
C0005803 (UMLS CUI [2,1])
C0600109 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Substance Use Disorders
Item
history of drug or alcohol abuse
boolean
C0038586 (UMLS CUI [1])
Investigational New Drugs
Item
receipt of the investigational drug within the last month prior to this trial
boolean
C0013230 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related Investigational New Drugs
Item
known or suspected allergy to trial products or related products
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
C0013230 (UMLS CUI [2,4])
Uncontrolled hypertension Severe
Item
severe uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Disease Interferes with Clinical Trial | Condition Interferes with Clinical Trial
Item
any disease or condition, which the investigator feels, would interfere with the trial
boolean
C0012634 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial